ReviewInternal and emergency medicine2017
Idiopathic retroperitoneal fibrosis and its overlap with IgG4-related disease.
Review in Internal and emergency medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
31 citing papers in PubMed, 86 citations in OpenAlex.
- IgG4-Related Kidney Disease and IgG4-Related Retroperitoneal Fibrosis: An Update on Diagnosis and Treatment.Kidney international reports · 2026Review
- IgG4-Related Retroperitoneal Fibrosis Presenting as Obstructive Acute Kidney Injury: A Case Report.Cureus · 2026Article
- A rare case of immunoglobulin G4-related periarteritis mimicking pancreatic cancer.Clinical journal of gastroenterology · 2026Article
- Case Report: Ureteral obstruction reveals rare underlying fibro-inflammatory, infiltrative, and proliferative disorders: report of four cases.Frontiers in immunology · 2026Article
- [European journal of nuclear medicine and molecular imaging · 2026Article
- Treatment and evolution of 134 patients with aortitis and periaortitis: experience of a third-level university hospital.Internal and emergency medicine · 2026Observational
- Idiopathic retroperitoneal fibrosis arising from peritoneal space: A case report and review of literature.World journal of gastroenterology · 2025Review
- Idiopathic Retroperitoneal Fibrosis-Related Hydronephrosis: Evaluation of Comprehensive Management and Prediction of Inflammatory Markers for Stent-Free Outcomes.International journal of general medicine · 2025Article
- Renal Manifestations of IgG4-Related Disease: A Concise Review.International journal of nephrology · 2024Review
- CT andThe Journal of international medical research · 2023Article
- Serum IgG4 Concentration Is a Potential Predictive Biomarker in Glucocorticoid Treatment for Idiopathic Retroperitoneal Fibrosis.Journal of clinical medicine · 2022Article
- A 61-Year-Old Woman Presenting with Low Back Pain Diagnosed with IgG4-Related Disease Affecting the Thoracoabdominal Aorta and Retroperitoneum.The American journal of case reports · 2022Article
- When idiopathic retroperitoneal fibrosis mimics Castleman disease: a challenging differential diagnosis.BMJ case reports · 2022Article
- Decreased absolute number of peripheral regulatory T cells in patients with idiopathic retroperitoneal fibrosis.Frontiers in immunology · 2022Article
- Concurrent presentation of IgG4-related tubulointerstitial nephritis and ANCA MPO crescentic glomerulonephritis.Clinical nephrology. Case studies · 2022Article
- [Immunoglobulin G4-Related Disease in the Thorax: Imaging Findings and Differential Diagnosis].Taehan Yongsang Uihakhoe chi · 2021Review
- A case of idiopathic retroperitoneal fibrosis presenting as gallbladder carcinoma.BMC surgery · 2021Article
- Improved clinical outcomes of tocilizumabTherapeutic advances in chronic disease · 2021Article
- Treatment Response to Idiopathic Retroperitoneal Fibrosis-associated Hydronephrosis With a Focus on IgG4/IgG3 Serum Concentration Ratio.Journal of rheumatic diseases · 2021Article
- Clinical characteristics of IgG4-related retroperitoneal fibrosis versus idiopathic retroperitoneal fibrosis.PloS one · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Retroperitoneal fibrosis (RPF) is a rare disease characterised by fibrous tissue proliferation in the retroperitoneum, with encasement of the ureters and large vessels of the abdomen as the most destructive of potentially severe complications. It can either be idiopathic, or secondary to infections, malignancies, or the use of certain drugs. The idiopathic form accounts for approximately 75% of the cases, and is usually responsive to immunosuppressive therapy. In recent years, the emergence of a new clinical entity, IgG4-related disease (IgG4-RD), shed light on many fibro-inflammatory disorders once thought to be separate clinical entities, although frequently associated in the so-called multifocal fibrosclerosis. Among these, together with sclerosing pancreatitis and cholangitis, pseudotumour of the orbit, idiopathic mediastinal fibrosis and other conditions, is idiopathic retroperitoneal fibrosis (IRF). Both IRF and IgG4-RD can be associated with a wide variety of disorders, usually governed by immune-mediated (and particularly auto-immune) mechanisms. In our review, we discuss the clinical and therapeutic challenges IRF presents to the internist, as well as the meaning of its recent inclusion in the IgG4-RD spectrum from a clinical practice standpoint.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.